A supply chain to match the changing face of science
Drug Discovery World
NOVEMBER 3, 2022
1 Emily was a seven-year-old girl who relapsed a second time following two years battling leukaemia, out of standard treatment options, and her life was saved by a CAR-T treatment in early clinical trial. They also do not have the potential of causing a severe immune response if they are administered to the wrong patient.
52 
Let's personalize your content